Ropers Majeski Announces Relocation of Paris Office to New Location
PARIS, May 01, 2024 (GLOBE NEWSWIRE) -- Ropers Majeski PC, a multi-service law firm recognized for its collaborative approach and global reach, is pleased to announce its Paris office's relocation to a new address at 5 rue La Boétie in Paris' central financial district. This strategic move signifies Ropers Majeski's improved accessibility within Paris and underscores the firm's ongoing commitment to strengthen its collaborative ties with its European clients.
"Moving to 5 rue La Boétie marks a significant milestone for our firm," said François Laugier, Head Partner of Ropers Majeski's Paris office. “This relocation reflects our commitment to excellence and positions us even more effectively to deliver enhanced legal solutions and support the continued success of our global US-based technology clients, and serve our multinational clients throughout France and the broader European market.”
François Laugier and his international team advise clients on a wide range of high-tech and cross-border transactions of all sizes as well as commercial and complex litigation. Their practice encompasses corporate formation, financing, international expansion, mergers and acquisitions, licensing, intellectual property, employment, and other commercial matters, including litigation when necessary.
About Ropers Majeski PC
Ropers Majeski is an established law firm that counsels clients in complex commercial litigation, sophisticated transactions, technology law, mergers and acquisitions, construction, employment, insurance, intellectual property, and restructuring. With nearly 100 lawyers in 8 offices worldwide, we offer clients coast-to-coast, results-driven legal representation. Our clients include leading corporations, start-ups and emerging companies, investors, municipalities, and government agencies. Large and established or new and feisty, Ropers Majeski is committed to providing strategic legal counsel that empowers clients to achieve their objectives.
Contacts:
Kalisha M. Crawford
Director of Marketing & Business Development
Ropers Majeski PC
(213) 312-2074
kalisha.crawford@ropers.com
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
SalMar – Meldepliktig handel21.5.2024 18:30:15 CEST | Pressemelding
Eva Haugen primærinnsider og direktør kvalitet/HMS har den 21.05.2024 solgt 7 900 aksjer i SalMar til en gjennomsnittlig kurs på 665 kroner per aksje. Etter salget eier Eva Haugen 0 aksjer og har 3 233 Restricted Share Units i SalMar. Vennligst se vedlagte dokument etter EUs markedsmisbruksforordning artikkel 19. Denne børsmeldingen er meldepliktig etter verdipapirhandelloven § 5-12. Vedlegg PDMR form - EHaugen
SalMar – Mandatory notification of trade21.5.2024 18:30:15 CEST | Press release
Eva Haugen primary insider and director quality management/HSE, has 21.05.2024 sold 7 900 shares in SalMar at a price of 665 NOK per share. After the transaction Eva Haugen owns 0 shares and 3,233 Restricted Share Units in SalMar. Please see attached document in accordance with the Market Abuse Regulation article 19. This notification has been submitted pursuant to the Securities Trading Act section 5-12. Attachment PDMR form - EHaugen
Repurchase of Shares21.5.2024 18:30:00 CEST | Press release
Repurchase of Shares Amsterdam, the Netherlands - Flow Traders Ltd. (Euronext: FLOW) has repurchased 75,900 of its own shares in the period from 13 May 2024 up to and including 17 May 2024 at an average price of €19.63. This is in accordance with the €15 million share buyback extension program originally announced on 27 October 2022, of which the period of execution was announced on 28 July 2023 to be extended by 12 months to 26 October 2024. The consideration of this purchase was €1.5 million. The total number of shares purchased under this program to date is 665,060 shares at an average price of €17.87 for a total consideration of €11.9 million. 2,427,442 shares were held in treasury as of 17 May 2024. Contact Details Flow Traders Ltd. Investors Eric Pan Phone: +31 20 7996180 Email: investor.relations@flowtraders.com About Flow Traders Flow Traders is a leading trading firm providing liquidity in multiple asset classes, covering all major exchanges. Founded in 2004, Flow Traders is a
Evs Communicates the Results of the Ordinary General Meeting21.5.2024 18:30:00 CEST | Press release
Publication on May 21, 2024, after market closure Regulated information EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS COMMUNICATES THE RESULTS OF THE ORDINARY GENERAL MEETING EVS Broadcast Equipment SA, leading provider of live video production systems, held its Ordinary General Meeting on May 21, 2024. In total 116 shareholders representing 3,860,045 shares, or 26.9% of the company shares, attended (by proxy and physically) the Ordinary General Meeting held physically at the company's registered office. All the resolutions have been approved, i.e.: - The remuneration report, the discharge of the Directors and the Auditor; - The 2023 annual accounts and the allocation of profits, including a total gross dividend of EUR 1.10 for fiscal year 2023 (such dividend is made up, on the one hand, of the interim dividend of EUR 0.50 gross per existing share, paid in November 2023 and, on the other hand, of a balance of EUR 0.60 gross per shar
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication21.5.2024 18:25:00 CEST | Press release
Nature Medicine published Up-LIFT pivotal trial results Company will discuss pivotal trial results during webcast this week with company leaders and study principal investigators and participants EINDHOVEN, the Netherlands, May 21, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that on Thursday, May 23rd at 2:30pm CET/8:30am ET following a brief Q1 Business Update, CEO Dave Marver will host a discussion of Up-LIFT pivotal trial results with a panel of company leaders, study principal investigators, and study participants. The Up-LIFT trial demonstrated the safety and effectiveness of external ARC-EX Therapy to improve hand and arm function after spinal cord injury. Panelists will include Up-LIFT principal investigators Drs. Jim Guest, Chet Moritz, and Candace Tefertiller, trial parti